ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Outcomes of Kidney Transplantation from HBsAg Positive Donors to HBsAb Positive Recipients

G. Chen, C. Wang, Z. Wu, X. Liu, C. Wang, L. Chen.

Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

Meeting: 2018 American Transplant Congress

Abstract number: A189

Keywords: Hepatitis B, Kidney transplantation, Outcome

Session Information

Session Name: Poster Session A: Kidney Transplant Goes Viral

Session Type: Poster Session

Date: Saturday, June 2, 2018

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall 4EF

Objective To investigate the outcomes of transplanting kidneys from HBsAg positive donors to HBsAb positive recipients.

Methods We retrospectively collected data of 57 kidney transplants from HBsAg positive donors to HBsAb positive recipients from January 2005 to December 2014. If HBsAb titer of recipient was between 100IU to 1000 IU, the recipient received anti-HBV immunoglobulin for two weeks and lamivudine or entecavir for 1 months in order to prevent HBV infection. If HBsAb titer of recipient was more than 1000IU, they only received lamivudine or entecavir for two weeks. HBV DNA was monitored every week in the first month and then every 1 month within 1 year.

Results No HBV infection was seen in these 57 recipients. No HBV DNA detected in these recipients after kidney transplantation. 5 recipients had hepatic function impairment, which might be caused by the side effects of immunosuppressive drugs.

Conclusion Kidney transplantation from HBsAg positive donors to HBsAb positive recipients is safe if given appropriate prophylactic anti-HBV treatment.

CITATION INFORMATION: Chen G., Wang C., Wu Z., Liu X., Wang C., Chen L. Outcomes of Kidney Transplantation from HBsAg Positive Donors to HBsAb Positive Recipients Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Chen G, Wang C, Wu Z, Liu X, Wang C, Chen L. Outcomes of Kidney Transplantation from HBsAg Positive Donors to HBsAb Positive Recipients [abstract]. https://atcmeetingabstracts.com/abstract/outcomes-of-kidney-transplantation-from-hbsag-positive-donors-to-hbsab-positive-recipients/. Accessed May 11, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences